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rates over many years need to be utilised to determine
baseline as well as excess mortality levels. In our study
mortality figures on their own over the past few years
contributed little to our knowledge of the extent of influenza.
An epidemic of influenza is diagnosed on both virological
criteria (the proof of the presence of influenza virus) together
with epidemiological criteria (based on the presence of these
nonspecific indicators). A number of definitions of an
epidemic or an epidemic threshold have been devised. For
example, the rise of the monthly incidence of influenza-like
illness beyond 400 per 100 000 inhabitants'6 or the isolation
• of influenza from at least 10% of submitted samples,7 or an
excess of cases of influenza-like illness and nonspecific
acute respiratory illness for 2 consecutive weeks above the
epidemic threshold"
The success of the influenza surveillance programme
depends directly on the interest and enthusiasm of the
sentinel doctors and the programme is an example par
excellence of how primary care physicians and biomedical
laboratories can co-operate and collaborate in a particularly
important preventive medical venture.
Our sincere thanks to all the sentinel doctors who assisted
so enthusiastically with the Witwatersrand Viral Watch
Surveillance Programme, as well as the principals and
secretaries of all the schools included in the absenteeism
surveillance programme. We would also like to thank Ms
Magda de Beer of the Department of Health, Housing and
Urbanisation of the City of Johannesburg, and Or J. Lundie
and Sr E. Joss for providing mortality data for the two
homes for the aged studied.
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Objectives. To assess the proportion of cases of community·
acquired pneumonia caused by 'atypical' bacteria, inclUding
the recently discovered Chlamydia pneumoniae, and to
compare the clinical, radiographic and laboratory features of
patients with and without 'atypical' bacteria.
Methods. A prospective serological study was carried out
on consecutive adult pneumonia patients from July 1987 to
July 1988. Acute and convalescent sera were tested in
batches for antibodies against Legionella pneumophila
serogroup 1, C. pneumoniae, Chlamydia psittaci, Coxiella
burnetii (phase-2 antigen) and Mycoplasma pneumoniae
(lgG and IgM). Records and chest radiographs were
examined retrospectively.
Results. Acute and convalescent sera were available from
113 patients. The records of 4 patients could not be traced
and 17 patients did not fulfil the inclusion criteria. Thirty-two
of these 92 patients (35,9%) were found to be infected with
'atypical' bacteria. The two most common organisms were
C. pneumoniae (20,7%) and L. pneumophila (8,7%). There.
were no differences in the clinical and radiographic features
of patients with and without 'atypical' bacteria. Clinicians
prescribed erythromycin or tetracyclines with equal
frequency in the two groups.
Conclusions. 'Atypical' bacteria, especially C.
pneumoniae, are a common cause of community-acquired
pneumonia in adults in South Africa. This is the first
demonstration of an aetiological role of C. pneumon.iae in
this country. We confirmed the finding of other studies that
there are no clinical, radiographic or laboratory features
characteristic of 'atypical' bacterial infection in hospitalised
patients. This has major implications for therapy, as these
organisms respond to erythromycin and tetracyclines, but·
not to ~-Iactam antibiotics.
S Afr Med J 1994; 84: 678-682.
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ARTICLES
Atypical pneumonia is a clinical syndrome first described by
Reimann in 1938.' There is no precise definition of this
syndrome! but the illness has a subacute onset with
constitutional symptoms and a dry cough. Radiographic
shadowing is characteristically non-segmental and more
extensive than the physical examination would suggest.
Leukocytosis is absent or moderate. The course is generally
benign. Mycoplasma pneumoniae is the most common
aetiological agent of atypical pneumonia. Other bacteria that
cause atypical pneumonia are Chlamydia psittaci, Legionella
spp. and Coxiella burnetii (the agent that causes Q fever)!
These organisms share three characteristics: they are not
visible on Gram stain, they do not grow on conventional
culture media and they do not respond to penicillins or
cephalosporins.
There is a widespread belief that pneumonia caused by
these organisms can readily be differentiated from
pneumonia due to conventional bacteria. However, the most
common radiographic finding in pneumonia due to these
four 'atypical' bacteria is unilateral consolidation, often lobar
or segmental,3-8 and the clinical features are generally
indistinguishable from those found in pneumonia caused by
conventional bacteria. 2.7,'0
Table I summarises four recent studies which show that
'atypical' bacteria cause a significant proportion of cases of
community-acquired pneumonia in adults. The major
differences in these studies are the incidence of
mycoplasma pneumonia, which occurs in cyclical epidemics
every few years," and legionella pneumonia which varies
geographically and temporally."
A fifth 'atypical' bacterium that causes pneumonia has
recently been discovered. Chlamydia pneumoniae (formerly
known as Chlamydia strain TWAR) was found to be
responsible for 12% of cases of mild pneumonia in college
students." Studies of hospitalised patients with community-
acquired pneumonia showed that C. pneumoniae caused
6 - 10% of cases. '.·20 It was also shown that there were no
differences in clinical or radiographic features of patients
with pneumonia caused by C. pneumoniae and those in
whom other pathogens were responsible. '8-20 A chlamydia
complement fixation test is Widely used to diagnose
psittacosis. This test is not species-specific and can be
positive in primary infections (but not re-infections) with
C. pneumoniae. 21 It is therefore likely that some cases of
psittacosis found in earlier pneumonia studies were in fact
causeo' ~"::. oneumoniae. Even so, roughly 20 - 40% of
patients ~ith ~ommuniiy-;:;~~uired pn~umonia will have
infections caused by 'atypical' bacter'i';. To date there IS no
commercially available test to detect C. pneumoniae
antibodies; this has hindered the investigation of the
aetiological role of this agent in community-acquired
pneumonia.
All of the studies quoted so far were performed in
developed countries. A previous study from this institution22
showed that 10% of cases were due to M. pneumoniae.
Other 'atypical' bacteria were not tested for in that study.
The aim of the current study was to assess the proportion of
cases of community-acquired pneumonia due to M.
pneumoniae, Legionella pneumophila, C. psittaci, C.
pneumoniae and C. burnetii in a developing country. A
secondary objective was to compare the clinical,
radiographic and laboratory features of patients with and
without 'atypical' bacteria.
Patients and methods
We evaluated consecutive adults with an admission
diagnosis of pneumonia from July 1987 to July 1988 at
Groote Schuur Hospital, a large community-based university
hospital. Pneumonia was defined as an acute respiratory
illness with compatible shadowing on chest radiograph
(performed on admission or within 48 hours). Patients with
pulmonary tuberculosis or severe immunosuppression (e.g.
in cases of AIDS) were excluded. Folders were
retrospectively reviewed for demographic data, underlying
illnesses, symptom duration, blood pressure values,
respiratory rate, presence of confusion, laboratory features
(P02, urea values, white cell count) and whether the chest
radiograph showed a segmental or non-segmental pattern
of pulmonary shadowing.
Microbiological methods
Acute and convalescent (2 - 4 weeks) sera were collected.
The study was originally set up to assess the incidence of
L. pneumophila. Paired sera were tested simultaneously for
L. pneumophila serogroup 1 by an indirect fluorescent
.antibody test (IFAT) method using antigen prepared in our
laboratory. Positive results were checked with control
antigen from the Centers for Disease Control (COG), Atlanta
lJSA. The sera were then frozen at -20°C and SUbsequently
tested in batches (avoiding multiple freeze-thaw) for IgM and
IgG antibodies against M. pneumoniae (IFAT, Diagnostic and
Technical Services), Q fever phase·2 antigen (I FAT, bio-
Merieux), C. psittaci (IFAT, bio-Merieux), and C. pneumoniae
(IFAT, antigen supplied by professor C. C. Kuo, Washington
UniverSity, USA). Definite infections were indicated by a
4-fold rise in titre or a titre of > 16 for M. pneumoniae IgM.
Probable infections were diagnosed when a single titre was
~ 64 for mycoplasma IgG, ~ 256 for C. psittaci, Q fever and
L. pneumophila, and ~ 512 for C. pneumoniae.2'
Results of sputum and blood cultures were recorded if the
clinicians looking after the patient had requested these
tests.
Table I. Proportion of community-acquired pneumonia cases caused by 'atypical' bacteria in studies of hospitalised adults .
Country
. Legionella spp. M. pneumoniae Q fever C. psittaci
No. of patients No. % No. % No. % No. % 'Atypical' bacteria (%)
19 15 3 2 1 < 1 7 6 24UK" 127
1 13 3 24UK" 453 9 2 81 18 5
3 < 1 1 < 1 185;::'t!in 15 462 64 14 16 3
3 3 8 8 0 5 5 15Australia''; 106
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Statistical methods
Clinical, laboratory and radiographic features of patients
with and without 'atypical' bacteria were compared. The
x'-test was used to analyse the categoric variables, while
Student's Hest (two-tailed) was used to analyse the
continuous variables.
The seasonal distribution of pneumonia cases is shown in







Fig. 1. Seasonal distribution of pneumonia cases.
COPD =chronic obstructive pulmonary disease.




















o No evidence of 'atypical' bacteria
Table Ill. Underlying conditions in patients with community-
acquired pneumonia
One hundred and seventy-three patients with an admission
diagnosis of pneumonia were entered in the study, but
convalescent serum was not obtained from 60 of these. The
records of the remaining 113 patients were reviewed. The
records of 4 patients could not be traced and 17 patients
did not fulfil the entry criteria for the study. This left 92
patients, 8 of whom were white, 23 black and 61 coloured.
We personally reviewed the radiographs of 72 patients.
Our reports correlated very closely with those of the
radiologists which were relied upon for the remaining 20
patients whose radiographs had been destroyed.
The results of the serological tests are shown in Table 11.
The patient with a 4-fold rise in titre to both C. pneumoniae
and C. psittaci presumably represents a cross-reaction. Five
of the patients with serological evidence of 'atypical' bacterial
infection also had sputum cultures positive for conventional
bacterial pathogens (3 Haemophilus influenzae, 2
Streptococcus pneumoniae). In the patients without
serological evidence of 'atypical' bacteria there were 5
positive blood cultures (4 S. pneumoniae and 1 Pseudomonas
aeruginosa) and sputum cultures were positive in an additional
9 (3 H. influenzae, 2 S. pneumoniae, 3 both S. pneumoniae
and H. influenzae; and 1 Staphylococcus aureus).
'One patient had a 4·101d rise in titre to both C. pneumoniae and C. psittaci.
















There were no differences in the demographic, clinical and
radiographic features of patients with and without
pneumonia due to 'atypical' bacteria (Table IV). The only
laboratory feature that was significantly different between
the two groups was the urea level, which was higher in the
group without 'atypical' bacteria.
The ability of the attending clinicians to distinguish
presence or absence of 'atypical' bacteria was assessed on
the basis of the prescription of erythromycin or tetracycline.
These antibiotics were prescribed for 6 of the 32 (19%)
patients with 'atypical' bacterial infections versus 12 of the
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60 (20%) without 'atypical' bacteria. According to the
records, they were prescribed because 'atypical' pneumonia
was suspected and not because of penicillin allergy. Four
patients, 2 from each group, required admission to an
intensive care unit, and both patients from the 'atypical'
group had L. pneumophila pneumonia.
Clinical, demographic and radiographic features of
patients with C. pneumoniae pneumonia did not differ
significantly from patients with other 'atypical' bacteria or
from the group without 'atypical' bacteria.
Discussion
We have shown that 'atypical' bacteria cause more than
one-third of cases of community-acquired pneumonia in
adults. C. pneumoniae was responsible for 20,7% of
pneumonia cases. This is higher than has been reported in
other serological surveys,17'20 but a similar proportion was
found in a study using culture and serology!3 C. pneumoniae
occurs in cyclical 4 - 6-year epidemics21 and our study was
presumably conducted during an epidemic year. The
proportion of cases of legionella pneumonia (8,7%) in this
study is intermediate between areas with a low,.·,6 and a
high"·15 incidence. Our fin.ding is an underestimate, as we
did not test for other L. pneumophila serogroups or other
LegioneJla spp., which collectively account for about half of
legionella pneumonia cases!4 There was no evidence of a
legionella outbreak, as the patients came from different
geographical areas at separate times.
. The only significant difference between patients with and
without 'atypical' bacteria was in the serum urea level, which
was lower in patients with 'atypical' bacteria. An elevated
urea level has been shown to be a poor prognostic factor in
pneumonia,'4 and is unlikely to help in the identification of
specific pathogens. In the current study, erythromycin or
tetracyclines were prescribed with the same frequency in
patients with and without 'atypical' bacteria; this further
emphasises that the two groups are indistinguishable.
Antibiotics directed against the enterobacteriaceae were
prescribed more frequently, despite the fact that these
organisms do not usually cause community-acquired
pneumonia.'3.,6.20Z1
In a recent large prospective study, Fang et al!° found no
characteristic features in hospitalised patients with
pneumonia due to 'atypical' bacteria and concluded that
the term 'atypical pneumonia' should be abandoned. Yung
et a/! commented that the term 'is only of value in the age
group of 10 - 60 years, in previously healthy patients, in
those with community-acquired disease and those without a
life-threatening illness'.
The majority of infections with 'atypical' bacteria are
. subclinical, and only a small minority of patients require
hospitalisation for pneumonia. An atypical presentation may
be associated more strongly with 'atypical' bacteria in mild
pneumonia not requiring admission. However, this has not
been addressed in a prospective study. Such a study would
be difficult to perform as atypical pneumonia is ill-defined,
and previous attempts at a definition have focused on
characteristics of 'atypical' bacteria."·26
Patients with pneumonia caused by 'atypical' bacteria




fact that most of our patients recovered without specific
therapy. However, recovery can be prolonged, and
appropriate therapy considerably shortens the course of the
illness.' Apart from legionella pneumonia, mortality from
pneumonia caused by other 'atypical' bacteria is generally
low··'·9.20." However, some studies have found that the
mortality rate of pneumonia caused by M. pneumoniae'4 or
C. pneumoniae,6.,9 is similar to that of pneumococcal
pneumonia.
Appropriate therapy for pneumonia caused by 'atypical'
bacteria is erythromycin or tetracyclines. Doxycycline is
probably the tetracycline of choice in this situation as it can
be taken twice daily and has better intracellular penetration
(all of these agents except M. pneumoniae are intracellular).
Erythromycin and tetracyclines are equally effecti\{e in M.
pneumoniae infections! but the tetracyclines seem to be
more active against chlamydia2 .2' Erythromycin is generally
regarded as the agent of choice for legionella pneumonia,
but tetracyclines are also effective 2 .27 There are very few
controlled trials comparing these two agents in pneumonia
caused by 'atypical' bacteria. A recent study has shown that
doxycycline is more active than erythromycin in cases of Q
fever!'
The specific aetiological agent should be sought in
hospitalised adults with community-acquired pneumonia
in order to direct antibiotic therapy. An urgent Gram stain
of an adequate sputum sample has proved a useful
investigation!022 Tuberculosis can manifest itself as an
acute pneumonia in our area!2 and a Ziehl-Neelsen stain
should be requested if the Gram stain is negative. If no
organism is identified, empirical therapy for patients with
mild-to-moderate pneumonia should cover S. pneumoniae,
which is the most common cause,'3.15.20Z1 or H. influenzae if
chronic obstructive pulmonary disease is present. Therapy
directed against 'atypical' bacteria can be added initially or if
.response is delayed or incomplete. Patients with pneumonia
caused by 'atypical' bacteria may respond to ~-Iactam
antibiotics if secondary bacterial infection is present; this
occurred in 5 of our patients and was a frequent finding in
other studies. ,4.'6Z1
In severe community-acquired pneumonia there is an
increased incidence of LegioneJla spp., S. aureus and the
enterobacteriaceae, although S. pneumoniae remains the
most common aetiological organism!9.3' The mortality rate in
this context is very high and some have argued that an early
invasive procedure to establish aetiology is justified.30 If no
organism is identified, then empirical therapy should cover
enterobacteriaceae and S. pneumoniae. Specific
antistaphylococcal therapy should be added in an influenza
epidemic, or if clinically indicated. The decision to add
intravenous erythromycin (which is very expensive) should
depend on the local incidence of legionella pneumonia. A
retrospective study from this institution found that legionella
pneumonia accounted for 5 of 95 patients with community-
acquired pneumonia requiring ICU admission.31 However,
serological tests were only performed in 40 patients and
were directed only at L. pneumophila. Mortality from severe
legionella pneumonia is considerably increased in patients
not receiving appropriate therapy!
The current study has several weaknesses. Firstly, the
clinical, radiographic and laboratory data were gathered
retrospectively. Secondly, no special attempts were made to
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identify conventional bacteria or viruses. Thirdly, more cases
of mild-to-moderate pneumonia were studied as
convalescent serum was an entry requirement; this resulted
in the exclusion of those who died from severe pneumonia.
Nevertheless, our conclusion that 'atypical' bacteria are a
major cause of community-acquired pneumonia in our area
remains valid. This has major implications for therapy.
This study was supported by the UCT Research Fund.
Etienne Theron's technological input was invaluable.
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The usefulness of
cerebrospinal fluid tests for
neurosyphilis
H. G. Russouw, M. C. Roberts, R. A. Emsley,
J.J.Joubert
To determine the usefulness of cerebrospinal fluid (CSF)
tests for syphilis at a large academic hospital, clinical and
laboratory data on 644 patients in whom such testing was
requested over a 12-month period were analysed. In 198
cases (31 %) the Treponema paJlidum haemagglutination
(TPHA) screening test could not be performed bec~use of
insufficient fluid. Thirty-eight of the remaining pati.ents
were diagnosed as having active neurosyphilis.
Examination of 22 files of patients who had a positive
TPHA and fluorescent treponemal antibody absorption
(FTA-Abs) test together with a negative CSF Venereal
Disease Research Laboratory (VDRL) test revealed that
other CSF measures indicating disease activity (CSF
protein, cells or IgG index) were not utilised optimally.
In 10 (45%) of these patients neurosyphilis was not
diagnosed despite either abnormal or incomplete CSF
biochemical analysis, indicating that if the CSF VDRL is
used as the sole marker for disease activity, some cases
of neurosyphilis are likely to be missed.
S Afr Med J 1994; 84: 682-684.
Notwithstanding the fact that neurosyphilis remains an
important cause of psychiatric morbidity, particularly in
developing countries such as South Africa,' uncertainty still
exists about the application and interpretation of
cerebrospinal fluid (CSF) tests for syphilis!·' This applies
particularly to patients whose clinical picture is not clear cut
when the CSF Treponema pallidum haemagglutination
(fPHA) or fluorescent treponemal antibody absorption (FTA-
Abs) tests are positive in the presence of a negative CSF
Venereal Disease Research Laboratory (VDRL) test.
The CSF VDRL test is generally regarded as the best
available test for active neurosyphilis, despite its low
sensitivity, which can result in some false negative results.
This sensitivity ranges between 10% and 89%, and is
lowest in asymptomatic neurosyphilis and tabes dorsalis.3
The TPHA and FTA-Abs tests are more sensitive and are
valuable as routine screening tests, but both remain positive
for an indefinite period after successful treatment: which
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